These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 30092774)

  • 41. [Baroreflex activation therapy. A novel interventional approach to treat heart failure with reduced ejection fraction].
    Halbach M; Fritz T; Madershahian N; Pfister R; Reuter H
    Herz; 2015 Nov; 40(7):959-65. PubMed ID: 26525523
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Baroreflex activation therapy with the Barostim™ device in patients with heart failure with reduced ejection fraction: a patient level meta-analysis of randomized controlled trials.
    Coats AJS; Abraham WT; Zile MR; Lindenfeld JA; Weaver FA; Fudim M; Bauersachs J; Duval S; Galle E; Zannad F
    Eur J Heart Fail; 2022 Sep; 24(9):1665-1673. PubMed ID: 35713888
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Baroreflex Activation Therapy for the Treatment of Heart Failure With a Reduced Ejection Fraction.
    Abraham WT; Zile MR; Weaver FA; Butter C; Ducharme A; Halbach M; Klug D; Lovett EG; Müller-Ehmsen J; Schafer JE; Senni M; Swarup V; Wachter R; Little WC
    JACC Heart Fail; 2015 Jun; 3(6):487-496. PubMed ID: 25982108
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cost-effectiveness of home versus clinic-based management of chronic heart failure: Extended follow-up of a pragmatic, multicentre randomized trial cohort - The WHICH? study (Which Heart Failure Intervention Is Most Cost-Effective & Consumer Friendly in Reducing Hospital Care).
    Maru S; Byrnes J; Carrington MJ; Chan YK; Thompson DR; Stewart S; Scuffham PA;
    Int J Cardiol; 2015 Dec; 201():368-75. PubMed ID: 26310979
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cost-effectiveness of remote haemodynamic monitoring by an implantable pulmonary artery pressure monitoring sensor (CardioMEMS-HF system) in chronic heart failure in the Netherlands.
    Mokri H; Clephas PRD; de Boer RA; van Baal P; Brugts JJ; Rutten-van Mölken MPMH
    Eur J Heart Fail; 2024 May; 26(5):1189-1198. PubMed ID: 38560762
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cost-Effectiveness Analysis of Patiromer and Spironolactone Therapy in Heart Failure Patients with Hyperkalemia.
    Bounthavong M; Butler J; Dolan CM; Dunn JD; Fisher KA; Oestreicher N; Pitt B; Hauptman PJ; Veenstra DL
    Pharmacoeconomics; 2018 Dec; 36(12):1463-1473. PubMed ID: 30194623
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-term cost-effectiveness analysis of nebivolol compared with standard care in elderly patients with heart failure: an individual patient-based simulation model.
    Yao G; Freemantle N; Flather M; Tharmanathan P; Coats A; Poole-Wilson PA;
    Pharmacoeconomics; 2008; 26(10):879-89. PubMed ID: 18793034
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cost utility analysis of endoscopic sinus surgery for chronic rhinosinusitis with and without nasal polyposis.
    Scangas GA; Remenschneider AK; Su BM; Shrime MG; Metson R
    Laryngoscope; 2017 Jan; 127(1):29-37. PubMed ID: 27440486
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cost-effectiveness of hip protector use on a geriatric ward in Germany: a Markov model.
    Stollenwerk B; Bartmus T; Klug F; Stock S; Müller D
    Osteoporos Int; 2015 Apr; 26(4):1367-79. PubMed ID: 25572047
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ex Ante Economic Evaluation of Arg389 Genetically Targeted Treatment with Bucindolol versus Empirical Treatment with Carvedilol in NYHA III/IV Heart Failure.
    Alkhatib N; Sweitzer NK; Lee CS; Erstad B; Slack M; Gharaibeh M; Karnes J; Klimecki W; Ramos K; Abraham I
    Am J Cardiovasc Drugs; 2021 Mar; 21(2):205-217. PubMed ID: 32710439
    [TBL] [Abstract][Full Text] [Related]  

  • 51. First outline and baseline data of a randomized, controlled multicenter trial to evaluate the health economic impact of home telemonitoring in chronic heart failure - CardioBBEAT.
    Hofmann R; Völler H; Nagels K; Bindl D; Vettorazzi E; Dittmar R; Wohlgemuth W; Neumann T; Störk S; Bruder O; Wegscheider K; Nagel E; Fleck E;
    Trials; 2015 Aug; 16():343. PubMed ID: 26259568
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical and Economic Benefits of Upper Airway Stimulation for Obstructive Sleep Apnea in a European Setting.
    Pietzsch JB; Richter AK; Randerath W; Steffen A; Liu S; Geisler BP; Wasem J; Biermann-Stallwitz J
    Respiration; 2019; 98(1):38-47. PubMed ID: 30923287
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Baroreceptor stimulation for resistant hypertension: first implantation in France and literature review.
    Courand PY; Feugier P; Workineh S; Harbaoui B; Bricca G; Lantelme P
    Arch Cardiovasc Dis; 2014 Dec; 107(12):690-6. PubMed ID: 25445751
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cost-Effectiveness Analysis of Natriuretic Peptide Testing and Specialist Management in Patients with Suspected Acute Heart Failure.
    Griffin EA; Wonderling D; Ludman AJ; Al-Mohammad A; Cowie MR; Hardman SMC; McMurray JJV; Kendall J; Mitchell P; Shote A; Dworzynski K; Mant J
    Value Health; 2017 Sep; 20(8):1025-1033. PubMed ID: 28964433
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cost-Effectiveness of Remote Cardiac Monitoring With the CardioMEMS Heart Failure System.
    Schmier JK; Ong KL; Fonarow GC
    Clin Cardiol; 2017 Jul; 40(7):430-436. PubMed ID: 28272808
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cost-effectiveness of cardiac resynchronization therapy: perspective from Argentina.
    Poggio R; Augustovsky F; Caporale J; Irazola V; Miriuka S
    Int J Technol Assess Health Care; 2012 Oct; 28(4):429-35. PubMed ID: 23006489
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cost-Utility Analysis of Telemonitoring Interventions for Patients with Chronic Obstructive Pulmonary Disease (COPD) in Germany.
    Hofer F; Achelrod D; Stargardt T
    Appl Health Econ Health Policy; 2016 Dec; 14(6):691-701. PubMed ID: 27475635
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cost-Effectiveness of Implantable Pulmonary Artery Pressure Monitoring in Chronic Heart Failure.
    Sandhu AT; Goldhaber-Fiebert JD; Owens DK; Turakhia MP; Kaiser DW; Heidenreich PA
    JACC Heart Fail; 2016 May; 4(5):368-75. PubMed ID: 26874380
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Telemonitoring Versus Usual Care for Elderly Patients With Heart Failure Discharged From the Hospital in the United States: Cost-Effectiveness Analysis.
    Jiang X; Yao J; You JH
    JMIR Mhealth Uhealth; 2020 Jul; 8(7):e17846. PubMed ID: 32407288
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cost-effectiveness of N-terminal pro-B-type natriuretic-guided therapy in elderly heart failure patients: results from TIME-CHF (Trial of Intensified versus Standard Medical Therapy in Elderly Patients with Congestive Heart Failure).
    Sanders-van Wijk S; van Asselt AD; Rickli H; Estlinbaum W; Erne P; Rickenbacher P; Vuillomenet A; Peter M; Pfisterer ME; Brunner-La Rocca HP;
    JACC Heart Fail; 2013 Feb; 1(1):64-71. PubMed ID: 24621800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.